Anglo-French’s journey began in 1923 when it was set up as a company, with the vision to make India self-sufficient in Nutrition healthcare. Anglo-French Drugs has emerged as one of the admired pharmaceutical companies, not just in India but also worldwide. We continue to support and improve millions of lives with high-quality drugs with the dedicated team of more than 750 employees supporting the medical fraternity to face the future challenges in healthcare.
We at Anglo-French Drugs are committed to address the unmet medical needs through our inherent expertise and perfection. Anglo French Drugs & Industries is acknowledged for being the first company in India to manufacture single vitamin injectables and a combination of B - complex Vitamins. We have emerged as a brand leader in the B-complex market and are positioned amongst the top 3 manufacturers in India. Today, Anglo French Drugs is a dynamic, rapidly expanding pharmaceutical company with established capabilities in the development of therapeutic formulations, marketing & sales and distribution
In the domestic market, our areas of focus include:
Vitamins, Anti-epileptics and Antioxidants. Sleep Inducing Agents, Cold & Cough preparations and Pain Management. Protein food supplements, Digestive Enzymes & Calcium supplement.
Milestone
Quality Policy
Management
Nitravet, Epilan & Papytazyme are the 3 text book brands mentioned in Martindale
With diversification in mind and to strengthen our market leadership we have launched a new division – Bonafide – Care to Bone health (exclusively dedicated to orthopaedic segment). Anglo-French Drugs is in the process of expanding with 2 more new divisions with additional field personnel. The initiative to implement ERP (SAP) has further enhanced our efficiency and has strongly complemented growth.